Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human CD125/IL5RA Antibody (SAA0047), APC

Catalog #:   FHF86313 Specific References (38) DATASHEET
Host species: Mouse
Isotype: IgG1, kappa
Applications: FCM
Accession: Q01344
Overview

Catalog No.

FHF86313

Species reactivity

Human

Host species

Mouse

Isotype

IgG1, kappa

Clonality

Monoclonal

Conjugation

APC

Target

IL-5R subunit alpha, IL-5 receptor subunit alpha, IL5RA, IL-5RA, IL-5R-alpha, Interleukin-5 receptor subunit alpha, CDw125, CD125, IL5R

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

Q01344

Applications

FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

SAA0047

Data Image
References

Remarkable increase in Interleukin-5 receptor expression beyond tissue eosinophils in inflammatory bowel disease., PMID:40475764

Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies., PMID:39864030

Effect of benralizumab on inflammation in skin after intradermal allergen challenge in patients with moderate-to-severe atopic dermatitis., PMID:39234416

Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis., PMID:38666394

Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis., PMID:38393328

Optimized flow cytometry protocol for dihydrorhodamine 123-based detection of reactive oxygen species in leukocyte subpopulations in whole blood., PMID:35760097

Are serum immunoglobulin concentrations a predictive biomarker of response to anti-IL5/IL5Rα therapies?, PMID:34983012

Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease., PMID:34144111

The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases., PMID:33779559

Molecular mechanism of asthma and its novel molecular target therapeutic agent., PMID:33549541

Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity., PMID:33488590

Genomic and phenotypic characterization of Investigator Global Assessment (IGA) scale-based endotypes in atopic dermatitis., PMID:33421484

Unsustained Response to Benralizumab in Eosinophilic Asthma After 3 Years of Therapy With Mepolizumab., PMID:33136004

Efficacy of Benralizumab and Clinical Course of IgG4 in Eosinophilic Granulomatosis With Polyangiitis., PMID:33030432

IL-5Rα marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease., PMID:32199912

Eosinophils, the IL-5/IL-5Rα axis, and the biologic effects of benralizumab in severe asthma., PMID:31734469

Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii., PMID:31427447

Targeting IL-5 in COPD., PMID:31190789

A case of severe eosinophilic asthma and refractory rheumatoid arthritis well controlled by combination of IL-5Rα antibody and TNFα inhibitor., PMID:31027977

Longitudinal trends of serum IgE and IL5RA expression throughout childhood are associated with asthma but not with persistent wheeze., PMID:31012487

Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome., PMID:30943337

Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-Analysis., PMID:30217529

Benralizumab for the treatment of asthma., PMID:29517082

FACS isolation of live mouse eosinophils at high purity via a protocol that does not target Siglec F., PMID:29253503

Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma., PMID:28530840

B-cells with a FasL expressing regulatory phenotype are induced following successful anti-tuberculosis treatment., PMID:28250925

Efficacy and Safety of Benralizumab, a Monoclonal Antibody against IL-5Rα, in Uncontrolled Eosinophilic Asthma., PMID:27119985

The role of interleukin 5 in asthma., PMID:27450970

A Simple, Rapid, and Highly Sensitive Electrochemical DNA Sensor for the Detection of α- and β-Thalassemia in China., PMID:27228385

Disentangling the effects of tocilizumab on neutrophil survival and function., PMID:26721805

Regulatory T-cell responses in chronic hepatitis B patients treated with nucleos(t)ide analogs compared with healthy subjects and untreated infected individuals., PMID:22626879

Flow cytometry analysis of leukocytes in induced sputum from asthmatic patients., PMID:22204819

Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry., PMID:21565196

Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity., PMID:19478395

Structure-based rationale for interleukin 5 receptor antagonism., PMID:18473871

Immunohistochemical analysis of an ectopic endometriosis in the uterine round ligament., PMID:16961927

Kinetic interaction analysis of human interleukin 5 receptor alpha mutants reveals a unique binding topology and charge distribution for cytokine recognition., PMID:14662768

Novel technique for the direct flow cytofluorometric analysis of human basophils in unseparated blood and bone marrow, and the characterization of phenotype and peroxidase of human basophils., PMID:10082306

Datasheet
$ 292
Product specifications
50 T 292 100 T 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human CD125/IL5RA Antibody (SAA0047), APC [FHF86313]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only